NeueHealth(NEUE) - 2025 Q1 - Earnings Call Transcript

Financial Data and Key Metrics Changes - New Health reported consolidated revenue of $215.8 million for Q1 2025, slightly lower than the previous year due to a shift in membership mix [9] - The first quarter gross margin was $54.9 million, and the company achieved adjusted EBITDA profitability for the fifth consecutive quarter, generating $13.5 million in adjusted EBITDA [9][10] Business Line Data and Key Metrics Changes - In the New Care segment, revenue was $90.5 million with an operating income of $23 million, serving 530,000 value-based consumers, representing a 67% increase over 2024 [10] - The New Solutions segment generated revenue of $127.6 million but reported an operating loss of $3 million, serving 138,000 consumers in the provider enablement business [10] Market Data and Key Metrics Changes - The company served over 709,000 consumers in Q1 2025, reflecting a growth of approximately 51% compared to Q1 2024 [4][10] - The diverse population base served across the ACA marketplace, Medicare, and Medicaid is critical for mitigating risks associated with high concentration in any one product area [6] Company Strategy and Development Direction - The company aims to continue advancing its value-driven consumer-centric care model, expanding its capabilities, and deepening partnerships with providers and payers [7][14] - Key growth areas include serving a diverse population, expanding in existing markets, and forming new relationships with payer groups [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strong position to continue driving value for consumers, providers, and payers, and highlighted the importance of trust-based relationships [5][7] - The anticipated transaction to go private, led by NEA, is expected to close in mid-2025, pending necessary conditions [7] Other Important Information - As of March 31, 2025, the company had total cash and investments of $239.4 million, with non-regulated cash and short-term investments at $145.1 million [11] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.